We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDS icon
126
GDS Holdings
GDS
$6.41B
$3.61M 0.11%
46,008
-135
-0.3% -$10.5K
DXC icon
127
CALL
DXC Technology
DXC
$1.73B
$3.58M 0.11%
+91,900
New +$3.28M
OWL icon
128
CALL
Blue Owl Capital
OWL
$18.5B
$3.57M 0.11%
+277,500
New +$3.14M
TLND
129
DELISTED
Talend S.A. American Depositary Shares
TLND
$3.56M 0.11%
+54,236
New +$3.51M
SWCH
130
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$3.54M 0.11%
167,890
-50,329
-23% -$964K
PMBC
131
DELISTED
Pacific Mercantile Bancorp
PMBC
$3.54M 0.11%
411,555
+344,468
+513% +$3M
PENN icon
132
CALL
PENN Entertainment
PENN
$2.7B
$3.52M 0.1%
55,300
-80,000
-59% -$6.89M
LKQ icon
133
LKQ Corp
LKQ
$6.29B
$3.51M 0.1%
71,314
-12,882
-15% -$615K
HON icon
134
Honeywell
HON
$78B
$3.48M 0.1%
16,842
+9,930
+144% +$2.1M
BRIVU
135
DELISTED
B. Riley Principal 250 Merger Corp. Units
BRIVU
$3.48M 0.1%
+350,000
New +$3.49M
BYD icon
136
Boyd Gaming
BYD
$6.06B
$3.46M 0.1%
56,180
-11,551
-17% -$729K
CNST
137
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$3.44M 0.1%
+101,865
New +$2.6M
WMT icon
138
Walmart Inc
WMT
$890B
$3.41M 0.1%
72,552
+11,499
+19% +$536K
AAC
139
DELISTED
Ares Acquisition Corporation
AAC
$3.39M 0.1%
347,450
+62,450
+22% +$613K
JNJ icon
140
Johnson & Johnson
JNJ
$625B
$3.39M 0.1%
20,557
+3,677
+22% +$609K
BEKE icon
141
KE Holdings
BEKE
$18.8B
$3.35M 0.1%
70,200
+56,765
+423% +$2.9M
XLY icon
142
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$3.34M 0.1%
37,400
+7,200
+24% +$627K
CNC icon
143
Centene
CNC
$32.5B
$3.32M 0.1%
45,578
+23,675
+108% +$1.62M
XLF icon
144
PUT
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$3.32M 0.1%
90,600
+2,500
+3% +$91.5K
CSTM icon
145
Constellium
CSTM
$3.99B
$3.32M 0.1%
175,316
+13,394
+8% +$231K
ATVI
146
DELISTED
Activision Blizzard
ATVI
$3.32M 0.1%
34,748
+19,206
+124% +$1.82M
CLVT icon
147
Clarivate
CLVT
$1.16B
$3.28M 0.1%
119,177
+36,527
+44% +$1M
GS icon
148
Goldman Sachs
GS
$303B
$3.26M 0.1%
8,581
-10,905
-56% -$3.9M
NTRA icon
149
Natera
NTRA
$46.1B
$3.23M 0.1%
28,450
-430
-1% -$44K
CAT icon
150
Caterpillar
CAT
$387B
$3.22M 0.1%
+14,809
New +$3.42M

Similar funds

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.